AVAH
Aveanna Healthcare Holdings Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$13.58
−0.44%Income statement
| Metric | TTM | 2026 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.6B | 2.4B | 2.0B | 1.9B | 1.8B |
| Cost of Revenue | 1.8B | 1.6B | 1.4B | 1.3B | 1.2B |
| Gross Profit | 831.7M | 805.2M | 635.5M | 595.4M | 553.2M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 402.1M | 526.7M | 470.5M | 464.7M | 483.9M |
| General & Admin Expense | 275.7M | 526.7M | 470.5M | 464.7M | 483.9M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 140.1M | 13.0M | 25.3M | 122.6M | 711.6M |
| Total Operating Expenses | 542.2M | 539.8M | 495.8M | 587.4M | 1.2B |
| Cost and Expenses | 2.3B | 2.2B | 1.9B | 1.9B | 2.4B |
| Operating Income (EBIT) | 289.5M | 265.4M | 139.8M | 8.1M | (642.3M) |
| Non-Operating | |||||
| Interest Income | 5.5M | 2.8M | 498.0K | 327.0K | 679.0K |
| Interest Expense | 124.7M | 140.1M | 156.6M | 153.2M | 107.7M |
| Net Interest Income | (119.2M) | (137.3M) | (156.1M) | (152.9M) | (107.0M) |
| Other Non-Op Income/Expense | (135.4M) | (158.4M) | (134.7M) | (147.1M) | (21.5M) |
| Non-Operating Income (excl Interest) | 10.7M | 14.6M | (16.4M) | (999.0K) | (78.4M) |
| EBT (Pre-Tax Income) | 154.1M | 106.9M | 5.1M | (139.0M) | (663.8M) |
| Income Tax Expense | (120.7M) | (118.1M) | 16.0M | (4.5M) | (1.8M) |
| Bottom Line | |||||
| Net Income | 274.8M | 225.0M | (10.9M) | (134.5M) | (662.0M) |
| Earnings from Cont. Ops | 274.8M | 225.0M | (10.9M) | (134.5M) | (662.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 274.8M | 225.0M | (10.9M) | (134.5M) | (662.0M) |
| Per Share | |||||
| Basic EPS | $1.33 | $1.10 | ($0.06) | ($0.71) | ($3.57) |
| Diluted EPS | $1.26 | $1.05 | ($0.06) | ($0.71) | ($3.57) |
| Revenue Per Share | $11.95 | $11.96 | $10.50 | $9.98 | $9.63 |
| Shares | |||||
| Basic Shares Outstanding | 217.8M | 203.5M | 192.9M | 190.0M | 185.6M |
| Diluted Shares Outstanding | 224.9M | 215.0M | 192.9M | 190.0M | 185.6M |
| Profitability Metrics | |||||
| EBITDA | 299.1M | 274.6M | 187.4M | 39.2M | (525.1M) |
| D&A | 20.4M | 23.8M | 31.2M | 30.1M | 38.8M |
| EBIT | 278.8M | 250.8M | 156.2M | 9.1M | (563.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026